The health tech industry is breathing a little sigh of relief after President Donald Trump revoked former President Joe Biden's executive order on artificial intelligence Monday. The repeal isn't likely to have a big impact. But some in the health industry had been worried about future implications of Biden's 2023 executive order, which, among other things, required companies with models trained using enormous computing power to regularly send detailed reports to federal regulators, regardless of the company's size.
A group of direct-to-consumer telehealth firms have become omnipresent across just about all media formats, seeking patients interested in their low-stigma, low-fuss, low-touch, high-convenience health products.
Since society rebounded from the pandemic, Teladoc Health has gone from a soaring rocket ship considered an emblem of the potential of health tech to a cautionary tale about overblown hype. Its telehealth services are now viewed by many as an interchangeable commodity in a crowded market.
Executives are aggressively pressing for all manner of gen AI deployments and experimentation despite knowing the risks — and CISOs are left holding the risk management bag.
Over the last four years, health systems across the United States have phased out the use of several clinical tools that use race to predict patient outcomes, replacing them with race-free versions that carry less risk of perpetuating inequitable care. But there's a wide world of other calculators and algorithms used to make decisions about patients every day — many of which use race, sex, and other traits protected by federal anti-discrimination laws. As a deadline for federally funded health systems to vet those tools for discrimination approaches in May, it's still unclear how they'll tackle the challenge.